Skip to main content
. Author manuscript; available in PMC: 2022 Oct 14.
Published in final edited form as: Eur J Heart Fail. 2022 May 29;24(8):1410–1414. doi: 10.1002/ejhf.2559

Figure 3.

Figure 3.

Comparison of baseline New York Heart Association Functional (NYHA) Class (A), Kansas City Cardiomyopathy Questionnaire (KCCQ) (B), 6-minute walk distance (C) and N-terminal pro natriuretic peptide (NT-proBNP) (D) compared to 1 month after greater splanchnic nerve ablation. Medians and interquartile range are provided unless otherwise specified. * Indicates a Wilcoxon signed rank test (compared to Baseline) p-value < 0.05.